GLP-1 analogs remain contraindicated during pregnancy, requiring alternative treatment approaches
Biological factors include: Starting body weight and BMI: Individuals with higher baseline weight may see larger absolute reductions, though percentage weight loss can vary
Semaglutide is generally discussed as a GLP-1 receptor agonist model, Tirzepatide as a dual GIP and GLP-1 receptor agonist model, and Retatrutide as a triple receptor agonist model involving GLP-1, GIP, and glucagon receptor pathways
Our structured nutrition coaching program teaches you how to eat for sustainable fat loss not extreme restriction
If air bubbles are present, tap the syringe gently and push the air out before redrawing the dose if needed
Treatment typically includes antifungal, keratolytic (scale-removing), anti-itch, and anti-inflammatory (steroid creams and calcineurin inhibitors) medications